| 5-HT |
5-Hydroxytryptamine (serotonin) |
| 5-HT1AR |
5-Hydroxytryptamine (serotonin) 1A Receptor |
| 5-HT2AR |
5-Hydroxytryptamine (serotonin) 2A Receptor |
| 5-HT2CR |
5-Hydroxytryptamine (serotonin) 2C Receptor |
| ARRIVE |
Animal Research: Reporting of In Vivo Experiments |
| BDNF |
Brain-Derived Neurotropic Factor |
| Bmax
|
Total density (concentration) of the receptor |
| BPND
|
Binding Potential (Non-displaceable) |
| BSA |
Bovine Serum Albumin |
| DMT |
N,N-dimethyltryptamine |
| DOI |
2,5-dimethoxy-4-iodoamphetamine |
| GPCR |
G-protein coupled receptor |
| KD
|
Equilibrium dissociation Constant |
| LSD |
Lysergic acid diethylamide |
| MAP2 |
Microtubule-associated protein 2 |
| mTOR |
Mammalian Target of Rapamycin |
| NSB |
Non-specific Binding |
| PET |
Positron Emission Tomography |
| pERK |
Endoplasmic Reticulum Protein Kinase |
| PFC |
Prefrontal Cortex |
| RCP |
Radiochemical purity |
| R-TLC |
Radio-Thin Layer Chromatography |
| SV2A |
Synaptic Vesicular Protein 2A |
| TB |
Total Binding |
| TE |
Tissue Equivalent |
| TrkB |
Tropomyosin Receptor Kinase B |
| VGLUT1 |
Vesicular Glutamate Transporter 1 |
|
|
Mean |